Our passion comes from focusing on the new chapter in cancer treatment, and we believe that next-generation immunotherapy will provide us with the best opportunity to discover and advance the drug pipeline for our global partners.
Creative Biolabs is developing state-of-the-art technologies and facilities to produce AAV, lentivirus and adenovirus with a rigorous GMP quality system to meet the needs and expectations of clinical material customers. We have established a strong process development and GMP team of virologists and technologists, experienced quality control (QC) professional and GMP research team to ensure end-to-end quality compliance. We offer flexible and high-quality GMP virus vectors, ranging from construction design to lentiviral vector production, concentration, and titration.